A study led by bioengineers at the University of California San Diego sheds new light on how a type of heart valve disease, called aortic valve stenosis, progresses differently in males and females.
Chantal Pelletier of Grand Falls, N.B. is sharing what her life is like wearing a left ventricular assist device (LVAD), a ...
A protocol for transitioning patients with heart failure and a left ventricular assist device to a stepdown unit from the ICU ...
One halcyon spring day in 1903, the 69-year-old anatomist and naturalist Dr. James Bell Pettigrew sat at the top of a sloping ...
The US Food and Drug Administration (FDA) accepted and granted Priority Review designation for Bayer’s (BAYN: DE) supplemental new drug application (sNDA) for a new indication for Kerendia (finerenone ...
Chantal Pelletier of Grand Falls, N.B. is sharing what her life is like wearing a left ventricular assist device (LVAD), a ...
Regulators are expected to make a decision in the third quarter of 2025 on Kerendia to treat patients with heart failure with ...
Bayer has won U.S. Food and Drug Administration priority review for its application seeking expanded approval of its kidney-disease drug Kerendia in certain people with heart failure.
Inter-atrial shunt device therapy has shown mixed results in clinical trials, with clinical 'non-responders' typically showing features of more advanced heart failure. We aimed to analyse the ...
4d
Sara Adair knew she was at risk for a life-threatening aortic dissection after her father and sister experienced the same ...
Oncology nurses play essential roles in the emerging field of cardio-oncology, which aims to protect patients’ heart function ...
Hypertrophic cardiomyopathy, also known as HCM or thick heart syndrome, is a genetic condition that causes your heart muscle ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback